ITIH2 and carcinoma: The literature describes that ITIH2 may present significant downregulation in solid tumors [27], contrary to the results obtained in the study by Kopylov and colleagues (2020) [26] and in our study, which observed a greater abundance of the ITIH2 protein in the malignant carcinoma group.